Strombafort 10 mg Balkan Pharmaceuticals

Principle of action of Strombafort 10 mg Balkan Pharmaceuticals and taking characteristics

All synthetic steroids are made from natural hormones found in the human body. Strombafort 10mg Balkan Pharmaceuticals contains stanozolol as its active ingredient, which is a derivative of dihydrotestosterone (a potent androgen). But, unlike its “relative”, its androgenic index is quite low.

The drug is approved for human use by the FDA. It can be considered relatively safe, as side effects are rare at low doses. The active substance does not aromatise, which is very important for bodybuilders and other athletes taking steroids.

Main positive properties of Strombafort 10 mg Balkan Pharmaceuticals

So what is Strombafort 10 mg Balkan Pharmaceuticals most commonly used for? First, for the drying course. The drug perfectly copes with the task of making the figure as expressive as possible, emphasizing the muscles, the visibility of veins and increasing stiffness.

In addition, due to the anabolic action, there is more strength and endurance. Weightlifters can withstand intense stress while taking steroids.

It is also able to eliminate excess fat in the abdomen and other areas and remove excess fluid from the tissues. If an athlete already has sufficient muscle mass, taking stanozolol alone, he gets an improvement in the quality of these muscles.

This steroid is ideal for combined cycles. In the human body there is a substance called globulin. It binds to sex hormones, preventing them from acting on the desired receptors. For this reason, not all steroids can work to their full potential. Stanozolol also reduces the amount of globulin, clearing the way for other steroids the athlete is taking.

Side effects and contraindications

The most common problem when using the remedy is joint pain and ligament trauma. This is due to the drug’s property of removing fluid from the tissues. The problem is solved by taking special joint and ligament supplements.

Other side effects occur in overdose:

• hypertension (high blood pressure);
• androgenic side effects;
• liver problems (due to toxicity of the tablets);
• increased levels of bad cholesterol.

Inhibition of its own testosterone production is not pronounced, but can occur if stanozolol is taken for a long time.

Contraindications are heart problems, enlarged prostate and other prostate diseases, liver diseases. Consult your doctor.

Recommendations for use

Strombafort 10 mg Balkan Pharmaceuticals can be used by athletes, boxers and beginners who are not familiar with the steroid. This dosage is sufficient to increase your endurance and strength as well as the drying effect.

The average dosage is 30-50 mg. For convenience, you can divide it into two doses per day.

Course duration: 4-6 days. By sticking to a short course, you can avoid joint problems.

Stanozolol and testosterone are considered the most successful combination in a combined course. Such a cycle will be more universal, the athlete will immediately receive both muscle growth and the formation of its expressiveness. In addition, testosterone will increase the amount of synovial fluid, which will protect the joints.

List of references

1. George AJ, Thorneycroft IH. Stanozolol and oxymetholone: effects on reproductive physiology, sex accessory organs, and steroid hormones in the rat. Pharmacology. 1993;47(6):364-375.
2. Evans NA. Current concepts in anabolic-androgenic steroids. Am J Sports Med. 2004;32(2):534-542.
3. Friedl KE, Dettori JR, Hannan CJ Jr. Dose effects of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in male bodybuilders. J Steroid Biochem Mol Biol. 1991;40(4-6):833-837.
4. Kanayama G, Gruber AJ, Pope HG Jr, Borowiecki JJ, Hudson JI. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom. 2001;70(3):137-140.
5. Santamarina RD, Besocke AG, Romano LM, Iannantuano R, López LM, Bonazzola P. Hepatic tumors related to anabolic androgenic steroids in an athlete. Ann Hepatol. 2013;12(2):306-309.